Chorioallantoic Membrane Assay as Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells

被引:0
|
作者
Merckx G. [1 ]
Tay H. [2 ]
Lo Monaco M. [1 ,3 ]
Van Zandvoort M. [4 ]
De Spiegelaere W. [2 ]
Lambrichts I. [1 ]
Bronckaers A. [1 ]
机构
[1] Faculty of Medicine and Life Sciences, Biomedical Research Institute (BIOMED), Hasselt University, Agoralaan, Building C, Room BMO-C012, Diepenbeek
[2] Department of Morphology, Faculty of Veterinary Medicine, Ghent University, Merelbeke
[3] Department of Veterinary Medicine, Faculty of Sciences, Integrated Veterinary Research, Unit-Namur Research Institute for Life Science (IVRU-NARILIS), University of Namur, Namur
[4] Department of Genetics and Cell Biology, School for Cardiovascular Diseases, CARIM, School for Oncology and Development GROW, Maastricht University, Maastricht
关键词
angiogenesis; chorioallantoic membrane assay; stem cells; tissue engineering;
D O I
10.1089/ten.teb.2020.0048
中图分类号
学科分类号
摘要
Tissue engineering aims to structurally and functionally regenerate damaged tissues, which requires the formation of new blood vessels that supply oxygen and nutrients by the process of angiogenesis. Stem cells are a promising tool in regenerative medicine due to their combined differentiation and paracrine angiogenic capacities. The study of their proangiogenic properties and associated potential for tissue regeneration requires complex in vivo models comprising all steps of the angiogenic process. The highly vascularized extraembryonic chorioallantoic membrane (CAM) of fertilized chicken eggs offers a simple, easy accessible, and cheap angiogenic screening tool compared to other animal models. Although the CAM assay was initially primarily performed for evaluation of tumor growth and metastasis, stem cell studies using this model are increasing. In this review, a detailed summary of angiogenic observations of different mesenchymal, cardiac, and endothelial stem cell types and derivatives in the CAM model is presented. Moreover, we focus on the variation in experimental setup, including the benefits and limitations of in ovo and ex ovo protocols, diverse biological and synthetic scaffolds, imaging techniques, and outcome measures of neovascularization. Finally, advantages and disadvantages of the CAM assay as a model for angiogenesis in tissue engineering in comparison with alternative in vivo animal models are described. The chorioallantoic membrane (CAM) assay is an easy and cheap screening tool for the angiogenic properties of stem cells and their associated potential in the tissue engineering field. This review offers an overview of all published angiogenic studies of stem cells using this model, with emphasis on the variation in used experimental timeline, culture protocol (in ovo vs. ex ovo), stem cell type (derivatives), scaffolds, and outcome measures of vascularization. The purpose of this overview is to aid tissue engineering researchers to determine the ideal CAM experimental setup based on their specific study goals. © 2020 Mary Ann Liebert, Inc., publishers.
引用
收藏
页码:519 / 539
页数:20
相关论文
共 50 条
  • [31] Critical appraisal of the chorioallantoic membrane model for studying angiogenesis in preclinical research
    Shekatkar, Madhura
    Kheur, Supriya
    Deshpande, Shantanu
    Sakhare, Swapnali
    Sanap, Avinash
    Kheur, Mohit
    Bhonde, Ramesh
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [32] Angiogenesis and Diabetes: Different Responses to Pro-Angiogenic Factors in the Chorioallantoic Membrane Assay
    Di Marco, Glovana S.
    Alam, Antoine
    Dol, Frederic
    Corvol, Pierre
    Gasc, Jean-Marie
    Larger, Etienne
    MOLECULAR MEDICINE, 2008, 14 (11-12) : 705 - 714
  • [33] In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma
    Shoji, Chika
    Kikuchi, Ken
    Yoshida, Hideki
    Miyachi, Mitsuru
    Yagyu, Shigeki
    Tsuchiya, Kunihiko
    Nakaya, Takaaki
    Hosoi, Hajime
    Iehara, Tomoko
    ONCOLOGY REPORTS, 2023, 49 (04)
  • [34] IN OVO CHORIOALLANTOIC MEMBRANE ASSAY AS A XENOGRAFT MODEL FOR PEDIATRIC RHABDOMYOSARCOMA
    Shoji, Chika
    Kikuchi, Ken
    Yoshida, Hideki
    Miyachi, Mitsuru
    Yagyu, Shigeki
    Tsuchiya, Kunihiko
    Nakaya, Takaaki
    Hosoi, Hajime
    Iehara, Tomoko
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S34 - S34
  • [35] Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model
    Larger, E
    Marre, M
    Corvol, P
    Gasc, JM
    DIABETES, 2004, 53 (03) : 752 - 761
  • [36] Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis
    Kirchner, LM
    Schmidt, SP
    Gruber, BS
    MICROVASCULAR RESEARCH, 1996, 51 (01) : 2 - 14
  • [37] Adipose-Derived Stem Cells Promote Angiogenesis and Tissue Formation for In Vivo Tissue Engineering
    Matsuda, Ken
    Falkenberg, Katrina J.
    Woods, Alan A.
    Choi, Yu Suk
    Morrison, Wayne A.
    Dilley, Rodney J.
    TISSUE ENGINEERING PART A, 2013, 19 (11-12) : 1327 - 1335
  • [38] Depletion of Embryonic Macrophages Leads to a Reduction in Angiogenesis in the Ex Ovo Chick Chorioallantoic Membrane Assay
    Tay, Hanna
    Du Cheyne, Charis
    Demeyere, Kristel
    De Craene, Jurgen
    De Bels, Lobke
    Meyer, Evelyne
    Zijlstra, Andries
    Spiegelaere, Ward De
    CELLS, 2021, 10 (01) : 1 - 15
  • [39] Future prospects in the tissue engineering of heart valves: a focus on the role of stem cells
    Albert, Benjamin J.
    Butcher, Jonathan T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (06) : 553 - 564
  • [40] Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay
    Kiriakidis, S
    Högemeier, O
    Starcke, S
    Dombrowski, F
    Hahne, JC
    Pepper, M
    Jha, HC
    Wernert, N
    BRITISH JOURNAL OF NUTRITION, 2005, 93 (03) : 317 - 323